Search

Search Constraints

You searched for: Author/Creator Reese, Adam

Search Results

1. Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration). Issue 3 (21st September 2021)

2. Outcomes of Lymph Node Dissection in Nephroureterectomy in the Treatment of Upper Tract Urothelial Carcinoma: Analysis of the ROBUUST Registry. Issue 2 (4th August 2022)

3. Outcomes of Lymph Node Dissection in Nephroureterectomy in the Treatment of Upper Tract Urothelial Carcinoma: Analysis of the ROBUUST Registry. Issue 2 (4th August 2022)

4. Outcomes of Lymph Node Dissection in Nephroureterectomy in the Treatment of Upper Tract Urothelial Carcinoma: Analysis of the ROBUUST Registry. Issue 2 (4th August 2022)

5. Outcomes of Lymph Node Dissection in Nephroureterectomy in the Treatment of Upper Tract Urothelial Carcinoma: Analysis of the ROBUUST Registry. Issue 2 (4th August 2022)

6. PD58-11 IMPACT OF PRE-OPERATIVE KIDNEY FUNCTION ON SURVIVAL OUTCOMES IN UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS OF THE ROBUUST REGISTRY. (May 2022)

7. MP10-08 LONGITUDINAL COMPARISON OF SURGICAL CASE LOGS BETWEEN FEMALE AND MALE: UROLOGY RESIDENTS. (May 2022)

8. MP31-05 LARGE SCALE IMPLEMENTATION OF OPIOID PRESCRIPTION REDUCTION AFTER ROBOTIC PROSTATECTOMY – 2 YEAR EVALUATION FROM THE PENNSYLVANIA UROLOGIC REGIONAL COLLABORATIVE (PURC). (May 2022)

9. PD41-10 THE UTILITY OF PSA DENSITY IN PATIENTS WITH PI-RADS 3 LESIONS ACROSS A LARGE MULTI-INSTITUTIONAL COLLABORATIVE. (May 2022)

10. PD58-07 IMPACT OF NODE COUNT ON SURVIVAL OUTCOMES OF LYMPH NODE DISSECTION IN NON-METASTATIC UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS OF THE ROBUUST REGISTRY. (May 2022)